Table 1.
Minimal concentration inhibitory of the Klebsiella pneumoniae OXA-48 producer and Escherichia coli J53 transconjugant.
| MIC (μg/mL) * | K. pneumoniae OXA-48-like | E. coli J 53 Transconjugant |
|---|---|---|
| IMI | 2 (Intermediate) | 2 (Intermediate) |
| MER | 2 (Intermediate) | <1 (Susceptible) |
| ERT | 4 (Resistant) | 4 (Resistant) |
| CAZ | <1 * (Susceptible) | <1 (Susceptible) |
| CTX | <1 * (Susceptible) | <1 (Susceptible) |
| FEP | <2 * (Susceptible) | <2 (Susceptible) |
| ATM | <2 (Susceptible) | <2 (Susceptible) |
| PIP/TAZ | >64/4 (Intermediate) | >64/4 (Intermediate) |
| CIP | >2 (Resistant) | <0.25 (Susceptible) |
| COL | 0.5 (Susceptible) | 0.25 (Susceptible) |
| AK | <4 (Susceptible) | <4 (Susceptible) |
| GEN | 8 (Intermediate) | 8 (Intermediate) |
| TGC | <0.25 (Susceptible) | <0.25 (Susceptible) |
| mCIM | POS | POS |
* Susceptible to third and four generation of cephalosporins. IMI: imipenem; MER: meropenem; ERT: ertapenem; CAZ: Ceftazidime; CTX: Cefotaxime; FEP: cefepime; ATM: aztreonam; PIP/TAZ: piperacillin/tazobactam; CIP: ciprofloxacin; COL: colistin; AK: amikacin; GEN: gentamicin; TGC: Tigecyclin; mCIM: modified carbapenem inactivation method.